Philip H. Coelho, Director at CATALYST PHARMACEUTICALS, INC. (CPRX), sold 30,000 shares at $15.70 ($472K) on 2022-09-13, disclosed to the SEC on 2022-09-15.
Open-market sale of $472k CPRX by Director. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Nothing distinguishes this filing.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $15.70 | 10,000 | $157K | 33.3% |
| 2 | $15.75 | 20,000 | $315K | 66.7% |
| Total | $15.73 avg | 30,000 | $472K | 100% |
| Filing → |
| AMPE | SELL | 2021-05-25 | $13K | — | Filing → |
| AMPE | SELL | 2021-04-29 | $7K | — | Filing → |
| AMPE | SELL | 2021-04-29 | $40K | — | Filing → |